These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21106745)

  • 1. Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine.
    Luke JM; Simon GG; Söderholm J; Errett JS; August JT; Gale M; Hodgson CP; Williams JA
    J Virol; 2011 Feb; 85(3):1370-83. PubMed ID: 21106745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
    Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
    J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity.
    Kulkarni RR; Rasheed MA; Bhaumik SK; Ranjan P; Cao W; Davis C; Marisetti K; Thomas S; Gangappa S; Sambhara S; Murali-Krishna K
    J Virol; 2014 Dec; 88(24):13990-4001. PubMed ID: 25253340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced neutralising antibody response to bovine viral diarrhoea virus (BVDV) induced by DNA vaccination in calves.
    R El-Attar LM; Thomas C; Luke J; A Williams J; Brownlie J
    Vaccine; 2015 Jul; 33(32):4004-12. PubMed ID: 26079613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant.
    Martínez-Gil L; Goff PH; Hai R; García-Sastre A; Shaw ML; Palese P
    J Virol; 2013 Feb; 87(3):1290-300. PubMed ID: 23175362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The virus-induced signaling adaptor molecule enhances DNA-raised immune protection against H5N1 influenza virus infection in mice.
    Luo M; Qu X; Pan R; Zhu D; Zhang Y; Wu J; Pan Z
    Vaccine; 2011 Mar; 29(14):2561-7. PubMed ID: 21303708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Intranasal Nanoemulsion and RIG-I Activating RNA Adjuvants Enhance Mucosal, Humoral, and Cellular Immunity to Influenza Virus.
    Wong PT; Goff PH; Sun RJ; Ruge MJ; Ermler ME; Sebring A; O'Konek JJ; Landers JJ; Janczak KW; Sun W; Baker JR
    Mol Pharm; 2021 Feb; 18(2):679-698. PubMed ID: 32491861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus.
    Xu K; Ling ZY; Sun L; Xu Y; Bian C; He Y; Lu W; Chen Z; Sun B
    Viral Immunol; 2011 Feb; 24(1):45-56. PubMed ID: 21319978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDA5 can be exploited as efficacious genetic adjuvant for DNA vaccination against lethal H5N1 influenza virus infection in chickens.
    Liniger M; Summerfield A; Ruggli N
    PLoS One; 2012; 7(12):e49952. PubMed ID: 23227156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PACT- and RIG-I-Dependent Activation of Type I Interferon Production by a Defective Interfering RNA Derived from Measles Virus Vaccine.
    Ho TH; Kew C; Lui PY; Chan CP; Satoh T; Akira S; Jin DY; Kok KH
    J Virol; 2016 Feb; 90(3):1557-68. PubMed ID: 26608320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus.
    Mibayashi M; Martínez-Sobrido L; Loo YM; Cárdenas WB; Gale M; García-Sastre A
    J Virol; 2007 Jan; 81(2):514-24. PubMed ID: 17079289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the immune response to recombinant DNA vaccine and adenoviral vaccine co-expressing the M1 and HA genes of H5N1 influenza virus in mice.
    Guo J; Yao L; Chen A; Liu X; Fu J; Xu P; Zhang Z
    Sheng Wu Gong Cheng Xue Bao; 2011 Jun; 27(6):876-83. PubMed ID: 22034816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response.
    Probst P; Grigg JB; Wang M; Muñoz E; Loo YM; Ireton RC; Gale M; Iadonato SP; Bedard KM
    Vaccine; 2017 Apr; 35(15):1964-1971. PubMed ID: 28279563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baculovirus vector as an avian influenza vaccine: hemagglutinin expression and presentation augment the vaccine immunogenicity.
    Chen CY; Lin SY; Cheng MC; Tsai CP; Hung CL; Lo KW; Hwang Y; Hu YC
    J Biotechnol; 2013 Mar; 164(1):143-50. PubMed ID: 23313887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate.
    Ablasser A; Bauernfeind F; Hartmann G; Latz E; Fitzgerald KA; Hornung V
    Nat Immunol; 2009 Oct; 10(10):1065-72. PubMed ID: 19609254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus virus-associated RNAs induce type I interferon expression through a RIG-I-mediated pathway.
    Minamitani T; Iwakiri D; Takada K
    J Virol; 2011 Apr; 85(8):4035-40. PubMed ID: 21248047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel synthetic plasmid and Doggybone DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice.
    Scott VL; Patel A; Villarreal DO; Hensley SE; Ragwan E; Yan J; Sardesai NY; Rothwell PJ; Extance JP; Caproni LJ; Weiner DB
    Hum Vaccin Immunother; 2015; 11(8):1972-82. PubMed ID: 26091432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological evaluation of vector-expressed M2 and HA genes of H5N1 influenza virus in mice].
    Guo J; Yao L; Chen A; Xu Y; Liu X; Shu Y; Zhang Z
    Sheng Wu Gong Cheng Xue Bao; 2010 May; 26(5):649-56. PubMed ID: 20684310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.
    Smith LR; Wloch MK; Ye M; Reyes LR; Boutsaboualoy S; Dunne CE; Chaplin JA; Rusalov D; Rolland AP; Fisher CL; Al-Ibrahim MS; Kabongo ML; Steigbigel R; Belshe RB; Kitt ER; Chu AH; Moss RB
    Vaccine; 2010 Mar; 28(13):2565-72. PubMed ID: 20117262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.